SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001213900-22-083042 from MDxHealth SA (MDXH) (CIK 0001872529) (MDXH)

MDxHealth SA (MDXH) (CIK 0001872529)
Date: Dec. 28, 2022 · CIK: 0001872529 · Accession: 0001213900-22-083042

AI Filing Summary & Sentiment

File numbers found in text: 333-268885

Date
December 28, 2022
Author
Not clearly detected
Form
CORRESP
Company
MDxHealth SA (MDXH) (CIK 0001872529)

Letter

Re: MDxHealth SA

December 28, 2022

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jordan Nimitz

Registration Statement on Form F-3

File No. 333-268885

Acceleration Request

Requested Date: December 30, 2022

Requested Time: 4:30 p.m., Eastern Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, MDxHealth SA hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement to 4:30 p.m., Eastern Time, on December 30, 2022, or as soon thereafter as practicable or at such later time as the Company may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.

Please confirm once the Registration Statement has been declared effective by calling Mark Busch of K&L Gates LLP at (704) 331-7440. Please also contact him should you have any questions.

/s/ Michael McGarrity

Michael McGarrity

Chief Executive Officer

cc:

Mark R. Busch, Esq.

K&L Gates LLP

Show Raw Text
CORRESP
1
filename1.htm

December 28, 2022

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jordan Nimitz

Re: MDxHealth SA

Registration Statement on Form F-3

File No. 333-268885

Acceleration Request

Requested Date: December 30, 2022

Requested Time: 4:30 p.m., Eastern
Time

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended,
MDxHealth SA hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration
Statement to 4:30 p.m., Eastern Time, on December 30, 2022, or as soon thereafter as practicable or at such later time as the Company
may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission.

Please confirm once the Registration Statement has been declared effective
by calling Mark Busch of K&L Gates LLP at (704) 331-7440. Please also contact him should you have any questions.

    /s/ Michael McGarrity

    Michael McGarrity

    Chief Executive Officer

cc:

Mark R. Busch, Esq.

K&L Gates LLP